VBI Vaccines Inc
F:LO9A

Watchlist Manager
VBI Vaccines Inc Logo
VBI Vaccines Inc
F:LO9A
Watchlist
Price: 0.0845 EUR Market Closed
Market Cap: 2m EUR

Wall Street
Price Targets

LO9A Price Targets Summary
VBI Vaccines Inc

There are no price targets for LO9A.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
VBI Vaccines Inc Competitors:
Price Targets
688177
Bio-Thera Solutions Ltd
57% Upside
1530
3SBio Inc
49% Upside
SLS
Sellas Life Sciences Group Inc
143% Upside
IVVD
Invivyd Inc
178% Upside
BIIB
Biogen Inc
4% Upside
NVAX
Novavax Inc
91% Upside
CRBU
Caribou Biosciences Inc
568% Upside
ABOS
Acumen Pharmaceuticals Inc
209% Upside

Revenue
Forecast

Revenue Estimate
VBI Vaccines Inc

For the last 7 years the compound annual growth rate for VBI Vaccines Inc's revenue is 48%. The projected CAGR for the next 3 years is 90%.

48%
Past Growth
90%
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Operating Income
Forecast

Operating Income Estimate
VBI Vaccines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
VBI Vaccines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LO9A's stock price target?
Not Available

LO9A doesn't have any price targets made by Wall Street professionals.

What is VBI Vaccines Inc's Revenue forecast?
Projected CAGR
90%

For the last 7 years the compound annual growth rate for VBI Vaccines Inc's revenue is 48%. The projected CAGR for the next 3 years is 90%.

Back to Top